PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $174,000 | +54.0% | 18,979 | +62.8% | 0.02% | +30.8% |
Q1 2021 | $113,000 | -21.0% | 11,657 | -17.5% | 0.01% | -43.5% |
Q3 2020 | $143,000 | -49.8% | 14,124 | -58.1% | 0.02% | -58.9% |
Q1 2020 | $285,000 | +9.2% | 33,731 | +13.0% | 0.06% | +33.3% |
Q4 2019 | $261,000 | +4.4% | 29,844 | +28.5% | 0.04% | -4.5% |
Q3 2019 | $250,000 | -27.7% | 23,217 | +160.3% | 0.04% | -22.8% |
Q1 2019 | $346,000 | +10.2% | 8,921 | -42.2% | 0.06% | +5.6% |
Q4 2018 | $314,000 | +33.6% | 15,430 | +340.9% | 0.05% | -14.3% |
Q3 2016 | $235,000 | – | 3,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |